Azilsartan Kamedoxomil contains not less than 97.0% and not more than 102.0% of C30H23KN4O8, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

㗁咪唑二㗁酯拮壓鉀鹽
Azilsartan Kamedoxomil

申請商
盛佳國際股份有限公司 
適應症
降血壓藥
含量
發證日期
2024-01-09